NASDAQ · QCLSHealthcareDiagnostics

Q/C Technologies financials

$0.8933+7.25%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Revenue$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00
Gross margin————
Operating income-$6.8M-$1.9M-$3.7M-$1.8M
Net income-$6.5M-$1.5M-$6.6M-$3.7M
Net margin————
Diluted EPS$-0.79$-0.19—$-2.50
EBITDA-$3.6M-$1.9M-$3.7M-$1.8M
Operating cash flow-$1.8M-$3.3M-$3.2M-$1.2M
Free cash flow-$2.0M-$3.3M-$3.2M-$1.2M
Diluted shares8.2M8.1M—1.5M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30
Cash & equivalents$307.6K$1.1M$987.0K$6.9M
Short-term investments$10.7M$11.8M$14.8M$3.1M
Total debt$0.00$0.00$0.00$0.00
Total assets$22.9M$38.3M$41.2M$37.2M
Total liabilities$3.8M$14.6M$16.4M$15.9M
Shareholders' equity$16.1M$20.7M$21.8M$14.3M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology